




























参考图片
Flow cytometric analysis of FoxP3 expressed in human lymphocytes. Human peripheral blood mononuclear cells (PBMC) were stained with FITC anti-human CD4 (clone RPA-T4, Cat. No. 555346) and APC anti-human CD25 (clone 2A3, Cat. 340938) simultaneously. The PBMC were fixed and permeabilized (see Recommended Assay Procedure) followed by intracellular staining with PE anti-human FoxP3 (clone 236A; Cat No. 560852). Two-color flow cytometric dot plots were derived from gated events based on the light scattering characteristics of lymphocytes and fluorescence characteristics of CD4+ or CD25+, respectively, shown as either FoxP3 versus CD25 (left panel) or CD4 versus FoxP3 (right panel). Flow cytometry was performed on a BD LSRII™ flow cytometry system.
Flow cytometric analysis of FoxP3 expressed in human lymphocytes. Human peripheral blood mononuclear cells (PBMC) were stained with FITC anti-human CD4 (clone RPA-T4, Cat. No. 555346) and APC anti-human CD25 (clone 2A3, Cat. 340938) simultaneously. The PBMC were fixed and permeabilized (see Recommended Assay Procedure) followed by intracellular staining with PE anti-human FoxP3 (clone 236A; Cat No. 560852). Two-color flow cytometric dot plots were derived from gated events based on the light scattering characteristics of lymphocytes and fluorescence characteristics of CD4+ or CD25+, respectively, shown as either FoxP3 versus CD25 (left panel) or CD4 versus FoxP3 (right panel). Flow cytometry was performed on a BD LSRII™ flow cytometry system.